Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	91.62	94.59	49.36
Graham Fair Price	-66.95	2.53	7.66
PEG	361.96	-0.98	0.21
Price/Book	-10.64	0.47	0.53
Price/Cash Flow	243.59	-70.55	20.53
Prices/Earnings	723.31	87.25	10.60
Price/Sales	3.83	3.12	3.00
Price/FCF	243.59	-70.55	20.53
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.29	0.47	0.46
Operating Margin	-73.86	0.03	0.10
ROA	-88.75	< 0.005	< 0.005
ROE	0.01	< 0.005	-89.15
ROIC	< 0.005	< 0.005	-89.26
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.01	0.04	-71.18
Dividends QOQ	-0.02	0.12	658.75
EBIT QOQ	< 0.005	-0.77	12868.41
EPS QOQ	0.50	-0.89	78.22
FCF QOQ	-0.50	-1.26	-149.66
Revenue QOQ	0.12	-0.14	10.87
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	141.34	146.82	3.88
Days Sales Outstanding (DSO)	4.77	29.31	514.74
Inventory Turnover	0.64	0.61	-3.73
Debt/Capitalization	0.48	0.48	0.48
Quick Ratio	0.28	0.33	18.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	14.50	14.55	0.33
Cash	4.82	3.00	-37.73
Capex	-0.38	0.07	-82.65
Free Cash Flow	0.37	-0.10	-73.91
Revenue	2.54	2.19	-13.66
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.47	0.45	-4.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	25.77	54.29	110.71
Naive Interpretation	Member

06 - Financial Health · Bad

Rating